NCT05799157: An ongoing trial by Veradermics, Inc.
This trial is ongoing. It must report results 2 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05799157 |
|---|---|
| Title | Protocol 250-1951-201: A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of VDMN-21 in Subjects With Verruca Vulgaris |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 28, 2023 |
| Completion date | Feb. 25, 2025 |
| Required reporting date | Feb. 25, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |